New insights into imiquimod's mechanisms of action.

Imiquimod, an immune response modifier with potent antiviral and antitumor properties, has been reported to be effective in the treatment of various cutaneous neoplasms. Besides stimulating the production of pro-inflammatory cytokines through Toll-like receptors on the surface of dendritic cells of monocyte-macrophage lineage, novel antiapoptotic mechanisms have been identified.
AuthorsRafael F Martín-García
JournalJournal of drugs in dermatology : JDD (J Drugs Dermatol) 2004 May-Jun Vol. 3 Issue 3 Pg. 247-9 ISSN: 1545-9616 [Print] United States
PMID15176157 (Publication Type: Journal Article, Review)
Chemical References
  • Adjuvants, Immunologic
  • Aminoquinolines
  • Antineoplastic Agents
  • Membrane Glycoproteins
  • Receptors, Cell Surface
  • Toll-Like Receptors
  • imiquimod
  • Adjuvants, Immunologic (administration & dosage, pharmacology, therapeutic use)
  • Administration, Cutaneous
  • Aminoquinolines (administration & dosage, pharmacology, therapeutic use)
  • Antineoplastic Agents (administration & dosage, pharmacology, therapeutic use)
  • Apoptosis (drug effects)
  • Humans
  • Membrane Glycoproteins (agonists, metabolism)
  • Receptors, Cell Surface (agonists, metabolism)
  • Skin Neoplasms (drug therapy)
  • Toll-Like Receptors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: